Raumedic has announced its new IT-based quality-assurance and production control system that is designed to help raise the quality of standards and efficiency of its production process.

The system is set to be installed in all of Raumedic’s production facilities in Germany and the U.S. by 2019. The company recently reached an agreement with the software provider Guardus Solutions to design the machine link for Raumedic’s existing machinery and any future machinery the company plans to get.

Raumedic’s manufacturing execution system (MES) will help take the transparency of the production operation of the polymer processor to a new level. The machinery status, production data and necessary work documents will be available all the time through a single platform under the new system.

MES will also help reduce the number of decentralized island systems, Excel lists and paper documents that Raumedic has and will simplify work for production employees.

Individual products will also be able to be tracked back to the raw material, be digitized, cross-linked, managed and documented from development to delivery.

“The use of digitized processes will not just open up undreamed of possibilities. Above all, it will boost the value that we can and will generate for our customers,” Martin Schenkel, head of operations at Raumedic, said in a press release.

“Medical technology and pharmaceuticals are sensitive business area that have extremely high quality requirements,” CEO Martin Bayer said.

Because of strict demands on the documentation of product and process data from government regulators, a central standardized data management system helps make significant improvements for customers.

“The system creates an optimal link between our quality control and production units,” Florian Pöhner, head of IT at Raumedic, said. “The MES is a consequential step for us and will enable us to take on future projects in terms of Industry 4.0.”

(See the best minds in medtech live at DeviceTalks Boston on Oct. 2.)